Potential role of IL-8, platelet-activating factor and TNF-alpha in the sequestration of neutrophils in the lung: effects on neutrophil deformability, adhesion receptor expression, and chemotaxis

Eur J Immunol. 2002 Feb;32(2):393-403. doi: 10.1002/1521-4141(200202)32:2<393::AID-IMMU393>3.0.CO;2-5.

Abstract

The microvasculature of the normal lung contains a pool of sequestered neutrophils, which is markedly enhanced in acute lung inflammation. Lung neutrophil sequestration is determined by the cells' deformability and adhesivity to capillary endothelium, and is a pre-requisite for emigration into the airspaces. We assessed the effect of several pro-inflammatory mediators associated with acute lung inflammation on these factors. Platelet-activating factor, IL-8 and formyl-Met-Leu-Phe (fMLP) induced a marked, but transient reduction in neutrophil deformability. Also, increased surface expression of the beta(2)-integrin and CD11b, and shedding of L-selectin (CD62L) was observed for these stimuli. TNF-alpha in contrast caused a small decrease in cell deformability only after 30 min, and shedding of L-selectin, but no change in CD11b levels. However, TNF-alpha-pretreatment markedly enhanced the fMLP response for cell deformability, CD11b expression and CD62L loss. Moreover, all pre-treatments were found to induce chemokinesis, and all except fMLP, enhanced fMLP-directed chemotaxis. We were able to demonstrate, using specific TNF-alpha receptor antagonists, that the TNF-alpha-induced changes in chemotaxis were mediated through the 55-kDa receptor. Also, inhibitors of the mitogen activated protein (MAP) kinase signaling pathway showed that the p38 MAP kinase pathway was involved for fMLP-directed chemotaxis of TNF-pretreated neutrophils, although activation of the extracellular signal-regulated kinase (ERK) pathway was also seen. These data demonstrate the differential role of pro-inflammatory mediators in controlling neutrophil sequestration and migration, which may orchestrate the severity of the inflammatory response in such respiratory diseases as chronic obstructive pulmonary disease and asthma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Adhesion
  • Cell Movement
  • Cell Size
  • Chemotaxis, Leukocyte / drug effects
  • Enzyme Activation / drug effects
  • Humans
  • In Vitro Techniques
  • Inflammation Mediators / pharmacology
  • Inflammation Mediators / physiology
  • Interleukin-8 / pharmacology
  • Interleukin-8 / physiology*
  • L-Selectin / metabolism
  • Lung / cytology*
  • Lung / immunology*
  • Macrophage-1 Antigen / metabolism
  • Mitogen-Activated Protein Kinases / metabolism
  • N-Formylmethionine Leucyl-Phenylalanine / pharmacology
  • Neutrophils / cytology
  • Neutrophils / drug effects
  • Neutrophils / immunology*
  • Neutrophils / physiology*
  • Platelet Activating Factor / pharmacology
  • Platelet Activating Factor / physiology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Inflammation Mediators
  • Interleukin-8
  • Macrophage-1 Antigen
  • Platelet Activating Factor
  • Tumor Necrosis Factor-alpha
  • L-Selectin
  • N-Formylmethionine Leucyl-Phenylalanine
  • Mitogen-Activated Protein Kinases